Navigation Links
Cardium Regains Listing Compliance With NYSE Amex
Date:7/7/2010

duct or procedure will be replicated in subsequent studies or in studies using newly-developed products or procedures, that regulatory approvals can be obtained in a timely manner or at all, that partnering, distribution or other commercialization efforts can be achieved, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that our products or proposed products will prove to be sufficiently safe and effective, that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive, that results or trends observed in one clinical study will be reproduced in subsequent studies, that third parties on whom we depend will behave as anticipated, or that necessary regulatory approvals will be obtained.  Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development, testing and marketing of biologics and medical devices and the conduct of human clinical trials, including the timing, costs and outcomes of such trials, whether our efforts to launch new biologics and devices and expand our markets will be successful or completed within the time frames contemplated, our dependence upon proprietary technology, our ability to obtain necessary funding, regulatory approvals and qualifications, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission.  We undertake no obligation to release publicly the results of any revisions to these forward-looking sta
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
2. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
3. Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
4. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
5. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
6. Cardium Announces Retirement of Director
7. Cardium Completes $3.5 Million Credit Facility
8. FDA has Granted HUD (Humanitarian Use Device) Designation to ITGIs Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
9. Cardium Announces Conference Call and Webcast to Review Recent Developments and Future Plans for the Excellarate(TM) Clinical Development Program
10. Cardiums InnerCool Therapies Business to Be Acquired By Royal Philips Electronics
11. Cardium Regains Listing Compliance with NYSE Amex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... BRYAN, Texas and COLLEGE STATION, Texas ... hotel theatlashotel.com will be a 177-key, 4-star ... Traditions in Bryan , Texas.  ... As the first hotel within ... will include 177 rooms, a mixture of standard rooms and suites, ...
(Date:7/26/2014)... Albany, NY (PRWEB) July 26, 2014 ... 2020 provides key market data on the Canada ... in millions of US dollars, volume (in units) ... segments - High-End Endoscopy Visualization Systems, Mid-Range Endoscopy ... Browse Full Report at http://www.marketresearchreports.biz/analysis/213254 . , ...
(Date:7/25/2014)... in each person,s digestive tract. Scientists believe that some ... harmful infections, but their role in human health is ... the role of these bacteria, a team of researchers ... fluctuations in the bacterial populations of two research subjects ... July 25 issue of the journal Genome Biology ...
(Date:7/25/2014)... According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 ... at USD 161,056.5 million in 2014 and is expected ... to 2020, to reach an estimated value of USD ... is witnessing a significant growth due to the increasing ...
Breaking Biology Technology:Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Monitoring the rise and fall of the microbiome 2Monitoring the rise and fall of the microbiome 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3
... , , HONG KONG, Dec. ... Company") (NYSE: CO ), China,s leading provider of ... stem cell storage services, today announced that the underwriters of ... portion of their over-allotment option, which will result in the ...
... EMERYVILLE, Calif., Dec. 29 Bionovo, Inc. (Nasdaq: BNVI ... on the anti-tumor mechanism of BN107. The results of ... , describe the potential molecular mechanisms mediating the selective pro-apoptotic ... (ER-) breast cancer cells. , Despite favorable advances that treatment ...
... , , , NEW YORK, Dec. 28 ... New Jersey, recently started using Twitter, the popular social networking tool, as ... new products and beauty trends to his patients and anyone else interested ... my patients on a more personal level. It provides a fun, easy ...
Cached Biology Technology:China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option 2China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option 3Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer 2Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer 3New York Plastic Surgeon Transforms His Practice Using Twitter Status Updates 2New York Plastic Surgeon Transforms His Practice Using Twitter Status Updates 3
(Date:7/25/2014)... July 25, 2014 In the first broad-scale estimate of ... scientists and collaborators calculated that trees are saving more ... incidences of acute respiratory symptoms. , While trees, pollution ... less than 1 percent, the impacts of that improvement ... the reduced air pollution at nearly $7 billion every ...
(Date:7/25/2014)... Terra satellite show the different areas that have been affected ... The burn scars show up as reddish-brown splotches of color ... the remote parts of Eastern Russia in the Sakha Republic. ... instrument, it is still possible to see the smoke rising ... below show the devastating number of fires that have plagued ...
(Date:7/25/2014)... and disrupted brain development is an essential part ... largely unknown. However, thanks to funding from the ... University (GW) researcher Anthony-Samuel LaMantia, Ph.D. may be ... to these key questions in the field of ... and physiology at the GW School of Medicine ...
Breaking Biology News(10 mins):First national study finds trees saving lives, reducing respiratory problems 2GW researcher receives grant to answer the how and why of autism during development 2
... Fairbanks, Alaska -- As the Arctic warms, greenhouse gases ... significantly higher levels than previous estimates, according to survey ... 30 issue of the journal Nature. Permafrost thaw ... deforestation, say the authors, but the effect on ...
... of North Carolina at Chapel Hill have shown that it ... an effort to create the ultimate vehicle for gene therapy. ... side effects from using a "chimeric" virus to deliver replacement ... dystrophy. "This trial demonstrates that gene therapy is no ...
... , MONTREAL, November 30, 2011 Take a Petri dish ... distinctive of the toxins that make up the fossil fuel. ... sit for two weeks in an incubator, and surprise, the ... petroleum!" says Mohamed Hijri, a professor of biological sciences and ...
Cached Biology News:Abrupt permafrost thaw increases climate threat 2Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy 2Petroleum-eating mushrooms 2Petroleum-eating mushrooms 3Petroleum-eating mushrooms 4
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
...
Biology Products: